Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Jacksonville › NPI 1417960626
Lab

Bernhardt Laboratories INC

Bernhardt Laboratories INC was paid $620K by Medicaid between Jan 2018 and Nov 2024, across 19 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 30% of everything it billed.

33Billing provider infoBERNHARDT LABORATORIES INC
JACKSONVILLE, FL 32207
33aNPI1417960626assigned 08/15/2006
28Total paid$620K
24GClaims53,704
24DCodes billed19
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#57 of 225
Median peer was paid$74K
This provider vs. median8.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20188,911$125K
20198,811$124K
20205,921$54K
20212,949$42K
20221,010$27K
202317,683$150K
2024incomplete8,419$98K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 30% 15,703 2,931 $185K
87481 25% 12,491 2,412 $156K
88305 Level IV - Surgical pathology, gross and microscopic examination 16% 5,752 4,064 $100K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 8.2% 3,509 2,407 $51K
87511 4.7% 2,598 1,581 $29K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 3.3% 3,294 1,760 $20K
87653 3.2% 1,450 1,189 $20K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 3.1% 3,481 2,376 $19K
87529 2.6% 1,347 404 $16K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1.8% 1,046 909 $11K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1.4% 1,942 1,700 $8K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 55 50 $3K
7 more codes
88342 <1% 53 $638.86
88312 <1% 190 $392.24
88141 <1% 51 $381.81
87625 <1% 19 $133.90
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 279 $21.90
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 74 $19.44
87563 0% 370 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVALLADARES, DINA (DIRECTOR, CREDENTIALING & PE)
Same official

Other billing entities under VALLADARES, DINA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.